Neuroborreliosis and acute encephalopathy: The use of CXCL13 as a biomarker in CNS manifestations of Lyme borreliosis

Karrasch M, Fingerle V, Boden K, Darr A, Baier M, Straube E, Nenadic I.
Ticks and Tick-borne Diseases, online first, 2017 Dec 11.

https://doi.org/10.1016/j.ttbdis.2017.12.008https://doi.org/10.1016/j.ttbdis.2017.12.008

Abstract

We report the case of an 80-year-old patient with acute onset confusion initially suspected to reflect delirium in incipient Alzheimer’s disease.

Cerebrospinal fluid tests revealed an unusually severe form of neuroborreliosis, which resolved following antibiotic treatment. This was mirrored in the measurement of CXCL13, which is suggested as a complementary biomarker.

Clinical implications for screening, differential diagnosis and treatment are discussed.

______________

For more:

https://madisonarealymesupportgroup.com/2017/06/10/the-coming-pandemic-of-lyme-dementia/

https://madisonarealymesupportgroup.com/2017/01/18/a-bug-for-alzheimers/

https://madisonarealymesupportgroup.com/2016/06/09/alzheimers-byproduct-of-infection/

https://madisonarealymesupportgroup.com/2016/11/17/antibiotics-and-alzheimers/

https://madisonarealymesupportgroup.com/2016/06/03/borrelia-hiding-in-worms-causing-chronic-brain-diseases/

https://madisonarealymesupportgroup.com/2017/10/03/treat-the-infection-psychiatric-symptoms-get-better/

https://madisonarealymesupportgroup.com/2017/11/01/lyme-mental-illness-dr-jane-marke/

https://madisonarealymesupportgroup.com/2017/06/04/minocycline-for-ms-and-much-more/